Predictive factors in locally advanced rectal cancer treated with preoperative hyperfractionated and accelerated radiotherapy
- 16 June 2003
- journal article
- Published by Elsevier in Human Pathology
- Vol. 34 (6) , 541-548
- https://doi.org/10.1016/s0046-8177(03)00176-x
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Importance of tumor regression assessment in predicting the outcome in patients with locally advanced rectal carcinoma who are treated with preoperative radiotherapyCancer, 2002
- Preoperative Radiotherapy Combined with Total Mesorectal Excision for Resectable Rectal CancerNew England Journal of Medicine, 2001
- Improved Survival and Reduction in Local Failure Rates After Preoperative RadiotherapyAnnals of Surgery, 1999
- Randomised trial of surgery alone versus radiotherapy followed by surgery for potentially operable locally advanced rectal cancerThe Lancet, 1996
- The rationale to switch from postoperative hyperfractionated accelerated radiotherapy to preoperative hyperfractionated accelerated radiotherapy in rectal cancerInternational Journal of Radiation Oncology*Biology*Physics, 1995
- Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlationsCancer, 1994
- Mesorectal excision for rectal cancerThe Lancet, 1993
- Preoperative short-term radiation therapy in operable rectal carcinoma: A prospective randomized trialCancer, 1990
- Pre- or Postoperative Radiotherapy in Rectal and Rectosigmoid Carcinoma Report from a Randomized Multicenter TrialAnnals of Surgery, 1990
- LOCAL RECURRENCE OF RECTAL ADENOCARCINOMA DUE TO INADEQUATE SURGICAL RESECTIONThe Lancet, 1986